Use of Aerosolized Aminoglycosides in the Treatment of Gram-Negative Ventilator-Associated Pneumonia

Abstract

Ventilator-associated pneumonia in critically ill patients is associated with substantial morbidity, longer ICU stays, and prolonged mechanical ventilation. Along with systemic therapy, aerosolized aminoglycosides are valuable adjuncts in select patients with minimal risk of antibiotic resistance.